|
1
|
Jochmanova I and Pacak K:
Pheochromocytoma: The first metabolic endocrine cancer. Clin Cancer
Res. 22:5001–5011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamidi O, Young WF Jr, Gruber L, Smestad
J, Yan Q, Ponce OJ, Prokop L, Murad MH and Bancos I: Outcomes of
patients with metastatic phaeochromocytoma and paraganglioma: A
systematic review and meta-analysis. Clin Endocrinol (Oxf).
87:440–450. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neumann HP, Bausch B, McWhinney SR, Bender
BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K,
et al: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl
J Med. 346:1459–1466. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Currás-Freixes M, Inglada-Pérez L,
Mancikova V, Montero-Conde C, Letón R, Comino-Méndez I,
Apellániz-Ruiz M, Sánchez-Barroso L, Aguirre Sánchez-Covisa M,
Alcázar V, et al: Recommendations for somatic and germline genetic
testing of single pheochromocytoma and paraganglioma based on
findings from a series of 329 patients. J Med Genet. 52:647–656.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fishbein L, Leshchiner I, Walter V,
Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA,
Ghayee HK, Else T, et al: Comprehensive molecular characterization
of pheochromocytoma and paraganglioma. Cancer Cell. 31:181–193.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Welander J, Andreasson A, Juhlin CC,
Wiseman RW, Backdahl M, Höög A, Larsson C, Gimm O and Söderkvist P:
Rare germline mutations identified by targeted next-generation
sequencing of susceptibility genes in pheochromocytoma and
paraganglioma. J Clin Endocrinol Metab. 99:E1352–E1360. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Turchini J, Cheung VKY, Tischler AS, De
Krijger RR and Gill AJ: Pathology and genetics of phaeochromocytoma
and paraganglioma. Histopathology. 72:97–105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wong NA: Gastrointestinal stromal
tumours-an update for histopathologists. Histopathology.
59:807–821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Perry CG, Young WF Jr, McWhinney SR, Bei
T, Stergiopoulos S, Knudson RA, Ketterling RP, Eng C, Stratakis CA
and Carney JA: Functioning paraganglioma and gastrointestinal
stromal tumor of the jejunum in three women: Syndrome or
coincidence. Am J Surg Pathol. 30:42–49. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakagaki T, Tamura M, Kobashi K, Koyama R,
Fukushima H, Ohashi T, Idogawa M, Ogi K, Hiratsuka H, Tokino T and
Sasaki Y: Profiling cancer-related gene mutations in oral squamous
cell carcinoma from Japanese patients by targeted amplicon
sequencing. Oncotarget. 8:59113–59122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Castro-Vega LJ, Buffet A, De Cubas AA,
Cascón A, Menara M, Khalifa E, Amar L, Azriel S, Bourdeau I, Chabre
O, et al: Germline mutations in FH confer predisposition to
malignant pheochromocytomas and paragangliomas. Hum Mol Genet.
23:2440–2446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Azarow KS, Pearl RH, Zurcher R, Edwards FH
and Cohen AJ: Primary mediastinal masses. A comparison of adult and
pediatric populations. J Thorac Cardiovasc Surg. 106:67–72.
1993.PubMed/NCBI
|
|
13
|
Takeda S, Miyoshi S, Minami M and Matsuda
H: Intrathoracic neurogenic tumors-50 years' experience in a
Japanese institution. Eur J Cardiothorac Surg. 26:807–812. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reyes MG, Fresco R and Bruetman ME:
Mediastinal paraganglioma causing spinal cord compression. J Neurol
Neurosurg Psychiatry. 40:276–279. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moran CA, Suster S, Fishback N and Koss
MN: Mediastinal paragangliomas. A clinicopathologic and
immunohistochemical study of 16 cases. Cancer. 72:2358–2364. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garibaldi E, Bresciani S, Panaia R,
Delmastro E, Malinverni G and Gabriele P: Hereditary paraganglioma
syndrome associated with SDHD gene mutations: A patient with
multicentric presentation treated with radiotherapy. Case report.
Tumori. 97:214–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baudin E, Habra MA, Deschamps F, Cote G,
Dumont F, Cabanillas M, Arfi-Roufe J, Berdelou A, Moon B, Al
Ghuzlan A, et al: Therapy of endocrine disease: Treatment of
malignant pheochromocytoma and paraganglioma. Eur J Endocrinol.
171:R111–R122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ayala-Ramirez M, Chougnet CN, Habra MA,
Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al
Ghuzlan A, Waguespack SG, et al: Treatment with sunitinib for
patients with progressive metastatic pheochromocytomas and
sympathetic paragangliomas. J Clin Endocrinol Metab. 97:4040–4050.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cassol CA, Winer D, Liu W, Guo M, Ezzat S
and Asa SL: Tyrosine kinase receptors as molecular targets in
pheochromocytomas and paragangliomas. Mod Pathol. 27:1050–1062.
2014. View Article : Google Scholar : PubMed/NCBI
|
